Beyond metabolic disease, the principles learned from GLP-1 could be applied to other conditions: for example, appetite-regulating pathways for addiction , or GLP-1s anti-inflammatory effects for liver disease
Normal-BMI Indians using GLP-1 for cosmetic weight loss Urban Indians with a BMI of 21 to 22 kg/m who take GLP-1s purely to look thinner often tolerate side effects poorly because they have limited metabolic and nutritional reserve
The data were fitted to a nonlinear substrate inhibition model ( y = V max x /( K m + x (1 + x / K i ))
It holds LegitScript certification, posts a clear HIPAA notice, has a verifiable US address in Austin, TX, and uses licensed physicians through Willow Medical of California, P.C
However, there are some confusing observations
The most pressing thing done, I think I can conclude this experiment